Trending...
- The Law Offices of Kameli & Associates is helping DV-2021 winners to File a Lawsuit Against the United States Government
- 3rd Annual Utility Cyber Security Forum, October 6-7, 2021 in Chicago
- Naperville Police Investigate Fatal Traffic Crash on Naper Boulevard
EVANSTON, Ill.--(BUSINESS WIRE)--Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of nervous system disorders, today announced that Norbert Riedel, Ph.D., chief executive officer, will participate in the "Brains of the Operation - Novel Approaches in Neuro" panel discussion at the Wedbush PacGrow Healthcare Virtual Conference on Tuesday, August 10 at 12:00 p.m. ET.
A live webcast of the presentation will be available to view on the "Events and Presentations" page in the "Investors & Media" section of Aptinyx's website at https://ir.aptinyx.com and will be archived on Aptinyx's website for 30 days following the event.
More on illi News
About Aptinyx
Aptinyx Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of proprietary synthetic small molecules for the treatment of brain and nervous system disorders. Aptinyx has a platform for discovery of novel compounds that work through a unique mechanism to modulate—rather than block or over-activate—NMDA receptors and enhance synaptic plasticity, the foundation of neural cell communication. The company has three product candidates in clinical development in central nervous system indications, including chronic pain, post-traumatic stress disorder, and cognitive impairment. Aptinyx is also advancing additional compounds from its proprietary discovery platform, which continues to generate a rich and diverse pipeline of small-molecule NMDA receptor modulators with the potential to treat an array of neurologic disorders. For more information, visit www.aptinyx.com or follow Aptinyx on Twitter @Aptinyx.
Source: Aptinyx Inc.
A live webcast of the presentation will be available to view on the "Events and Presentations" page in the "Investors & Media" section of Aptinyx's website at https://ir.aptinyx.com and will be archived on Aptinyx's website for 30 days following the event.
More on illi News
- Two-Thirds of Crypto Investors Buy-and-HODL
- 09:08 ET HARIBO of America Creates More Sweet Moments with the Launch of New Rainbow Worms and Z!NG Sour Kicks
- Rock & Roll Hall of Famer and Public Enemy co-founder bets big on Altavoz Entertainment
- Triangle Real Estate Agent Promotes Homes To MORE Buyers For MORE Money
- "Just Looking" Real Estate Program is a BIG Hit with Mississippi Area Residents
About Aptinyx
Aptinyx Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of proprietary synthetic small molecules for the treatment of brain and nervous system disorders. Aptinyx has a platform for discovery of novel compounds that work through a unique mechanism to modulate—rather than block or over-activate—NMDA receptors and enhance synaptic plasticity, the foundation of neural cell communication. The company has three product candidates in clinical development in central nervous system indications, including chronic pain, post-traumatic stress disorder, and cognitive impairment. Aptinyx is also advancing additional compounds from its proprietary discovery platform, which continues to generate a rich and diverse pipeline of small-molecule NMDA receptor modulators with the potential to treat an array of neurologic disorders. For more information, visit www.aptinyx.com or follow Aptinyx on Twitter @Aptinyx.
Source: Aptinyx Inc.
Filed Under: Business
0 Comments
Latest on illi News
- 13:30 ET Latham & Watkins Expands Structured Finance Practice in Chicago
- New gallery exhibits including FROM FALLUJAH featuring four contemporary photographers work from Fallujah
- Schulstad Bakery Solutions Unveils New European Fully-Baked Danish Pastries at the 2021 NACS Show
- Healthline Gate Launches its Health and Medical Information News Website
- Naperville Police Investigate a Home Invasion on 100 block of Whispering Hills Drive
- The New Real Estate "Just Looking" Program Is A Big Hit With Minneapolis Area Residents!
- Join Our 25th Year Celebration and Prayer for Peace Today
- The New Real Estate "Just Looking" Program Is A Big Hit With Chattanooga Tn and Northwest Ga Area Residents!
- One Park Financial, a Fund Street Technologies Brand, Wins Bronze Stevie® Award 3 Years in a Row
- Naperville Police Investigate Fatal Traffic Crash on Naper Boulevard
- Lee Enterprises Consulting Announces New Experts From Around the World
- New Real Estate "Just Looking" Program Is a Big Hit With Emerald Coast Home Buyers
- The New Real Estate "Just Looking: Program Is A Big Hit With Orange Beach/Gulf Shores Area Residents!
- The New Real Estate "Just Looking" Program Is A Big Hit With Central Virginia Area Residents!
- 2021 Mensa Select® Winners Announced
- The New Real Estate "Just Looking" Program Is A Big Hit With Triangle Area Residents!
- 3rd Annual Utility Cyber Security Forum, October 6-7, 2021 in Chicago
- Easy Blog SEO Content Optimization for Non-Techie Writers
- The Law Offices of Kameli & Associates is helping DV-2021 winners to File a Lawsuit Against the United States Government
- Swoop Airline will offer flights to Canada from St. Pete airport | Swoop Airline